Arkansas Children's Hospital Research Institute (ACHRI)

An open-label study to evaluate the single-dose pharmacokinetics and safety of ceftobiprole in pediatric subjects 3 months to < 18 years of age undergoing treatment with systemic antibiotics

Indications:
Infectious Disease

Study Description:
The study will measure the amount of study drug (ceftobiprole) in the blood of children after receiving one dose. The study will also see how well children tolerate one dose of the study drug (ceftobiprole).

Eligibility Requirements:
Children ages 3 months to < 18 years receiving systemic antibiotics. They must be in stable medical condition and be at normal height and weight for their age.

 

Request Information for This Trial

 

 

Joint Notice of Privacy Practices | Terms & Conditions of Use | Report Concerns About Patient Care & Safety | Site Index

About ACH | Your Visit to ACH | Community Outreach Programs
Medical Services | Career Opportunities | Volunteer Opportunities
ACH Foundation | Press Room | Resources | Research | Kids Only | Contact Us